These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19208395)

  • 1. Response to methotrexate in a chronic inflammatory demyelinating polyradiculoneuropathy patient.
    Díaz-Manera J; Rojas-García R; Gallardo E; Illa I
    Muscle Nerve; 2009 Mar; 39(3):386-8. PubMed ID: 19208395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody.
    Gono T; Matsuda M; Shimojima Y; Ishii W; Yamamoto K; Morita H; Hashimoto T; Susuki K; Yuki N; Ikeda S
    J Clin Neurosci; 2006 Jul; 13(6):683-7. PubMed ID: 16814550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
    Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
    RMC Trial Group
    Lancet Neurol; 2009 Feb; 8(2):158-64. PubMed ID: 19136303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Matsuda M; Hoshi K; Gono T; Morita H; Ikeda S
    J Neurol Sci; 2004 Sep; 224(1-2):29-35. PubMed ID: 15450768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coincident membranous glomerulonephritis and chronic inflammatory demyelinating polyradiculoneuropathy: questioning the autoimmunity hypothesis.
    Smyth S; Menkes DL
    Muscle Nerve; 2008 Jan; 37(1):130-5. PubMed ID: 17614320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy.
    Gladstone DE; Prestrud AA; Brannagan TH
    J Peripher Nerv Syst; 2005 Mar; 10(1):11-6. PubMed ID: 15703014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
    Wadwekar V; Kalita J; Misra UK
    Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of intravenous immunoglobulin in CIDP.
    Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
    Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammatory demyelinating polyradiculoneuropathy in children: characterized by subacute, predominantly motor dominant polyeuropathy with a favorable response to the treatment.
    Jo HY; Park MG; Kim DS; Nam SO; Park KH
    Acta Neurol Scand; 2010 May; 121(5):342-7. PubMed ID: 20003085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids.
    Muley SA; Kelkar P; Parry GJ
    Arch Neurol; 2008 Nov; 65(11):1460-4. PubMed ID: 19001164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant methotrexate in CIDP.
    Dyck PJ
    Lancet Neurol; 2009 Feb; 8(2):128-9. PubMed ID: 19136302
    [No Abstract]   [Full Text] [Related]  

  • 13. Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
    Leitch MM; Sherman WH; Brannagan TH
    Muscle Nerve; 2013 Feb; 47(2):292-6. PubMed ID: 23168526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy.
    Wolf C; Menge T; Stenner MP; Meyer zu Hörste G; Saleh A; Hartung HP; Wiendl H; Kieseier BC
    Arch Neurol; 2010 Jul; 67(7):881-3. PubMed ID: 20625098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.
    Harbo T; Andersen H; Jakobsen J
    Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A quadriplegic patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who responded well to corticosteroids and intravenous immunoglobulin therapy].
    Fukae J; Okuma Y; Noda K; Fujishima K; Goto K; Mizuno Y
    No To Shinkei; 2001 Dec; 53(12):1115-8. PubMed ID: 11806118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G; Pestronk A; Al-Lozi M
    Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine in chronic inflammatory demyelinating polyradiculoneuropathy.
    Visudtibhan A; Chiemchanya S; Visudhiphan P
    Pediatr Neurol; 2005 Nov; 33(5):368-72. PubMed ID: 16243226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate.
    Fialho D; Chan YC; Allen DC; Reilly MM; Hughes RA
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):544-7. PubMed ID: 16543541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inflammatory demyelinating polyneuropathy: a 6-year retrospective clinical study of a hospital-based population.
    Rentzos M; Anyfanti C; Kaponi A; Pandis D; Ioannou M; Vassilopoulos D
    J Clin Neurosci; 2007 Mar; 14(3):229-35. PubMed ID: 17258131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.